GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2026)
GE HealthCare Technologies filings provide 5 years of Cash from Investing Activities readings, the most recent being -$2.5 billion for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 514.25% to -$2.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.1 billion, a 177.14% decrease, with the full-year FY2025 number at -$1.0 billion, down 14.55% from a year prior.
- Cash from Investing Activities hit -$2.5 billion in Q1 2026 for GE HealthCare Technologies, down from -$269.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$84.0 million in Q2 2023 to a low of -$2.5 billion in Q1 2026.
- Median Cash from Investing Activities over the past 5 years was -$148.0 million (2025), compared with a mean of -$318.6 million.
- Biggest five-year swings in Cash from Investing Activities: surged 36.1% in 2025 and later tumbled 514.25% in 2026.
- GE HealthCare Technologies' Cash from Investing Activities stood at -$95.0 million in 2022, then rose by 7.37% to -$88.0 million in 2023, then crashed by 172.73% to -$240.0 million in 2024, then fell by 12.08% to -$269.0 million in 2025, then crashed by 829.37% to -$2.5 billion in 2026.
- The last three reported values for Cash from Investing Activities were -$2.5 billion (Q1 2026), -$269.0 million (Q4 2025), and -$148.0 million (Q3 2025) per Business Quant data.